IRadimed

IRadimed P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of IRadimed (IRMD) as of Oct 17, 2026 is 74.28. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 72.44 — a change of 2.55% (higher).

P/FCF

74.28

YoY

2.55%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of IRadimed is 2025 74.28 . P/FCF (Price-to-Free-Cash-Flow Ratio) of IRadimed was 2024 72.44 . It decreases by 2.55% higher compared to the previous year.

The IRadimed P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
179.48 USD
Jan 1, 2019
130.95 USD
Jan 1, 2020
246.36 USD
Jan 1, 2021
121.37 USD
Jan 1, 2022
156.27 USD
Jan 1, 2023
233.85 USD
Jan 1, 2024
72.44 USD
Jan 1, 2025
74.28 USD
The IRadimed P/FCF history
YEARP/FCFYoY
74.28+2.55%
72.44-69.02%
233.85+49.65%
156.27+28.76%
121.37-50.74%
246.36+88.14%
130.95-27.04%
179.48-63.56%
492.58+204.19%
161.93-6.95%
174.02-73.01%
644.80—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of IRadimed is 74.28 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of IRadimed changed from 72.44 to 74.28, representing a 2.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) IRadimed since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — IRadimed

All Key Metrics — IRadimed